$2.5T
Total marketcap
$192.14B
Total volume
BTC 50.02%     ETH 15.78%
Dominance

Avidity Biosciences RNA Stock

23.93 USD {{ price }} -2.006551% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
1.91B USD
LOW - HIGH [24H]
23.66 - 25.12 USD
VOLUME [24H]
1.92M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.91 USD

Avidity Biosciences Price Chart

Avidity Biosciences RNA Financial and Trading Overview

Avidity Biosciences stock price 23.93 USD
Previous Close 12.19 USD
Open 12.19 USD
Bid 0 USD x 800
Ask 0 USD x 900
Day's Range 12.15 - 12.71 USD
52 Week Range 9.83 - 25.74 USD
Volume 4.37M USD
Avg. Volume 1.41M USD
Market Cap 883.82M USD
Beta (5Y Monthly) -0.097524
PE Ratio (TTM) N/A
EPS (TTM) -2.91 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 37 USD

RNA Valuation Measures

Enterprise Value 287.09M USD
Trailing P/E N/A
Forward P/E -3.6814158
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 91.47418
Price/Book (mrq) 1.5811478
Enterprise Value/Revenue 29.713
Enterprise Value/EBITDA -1.431

Trading Information

Avidity Biosciences Stock Price History

Beta (5Y Monthly) -0.097524
52-Week Change -2.80%
S&P500 52-Week Change 20.43%
52 Week High 25.74 USD
52 Week Low 9.83 USD
50-Day Moving Average 12.67 USD
200-Day Moving Average 17.11 USD

RNA Share Statistics

Avg. Volume (3 month) 1.41M USD
Avg. Daily Volume (10-Days) 1.31M USD
Shares Outstanding 70.82M
Float 54.79M
Short Ratio 10.96
% Held by Insiders 5.17%
% Held by Institutions 102.96%
Shares Short 13.4M
Short % of Float 19.17%
Short % of Shares Outstanding 18.92%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -2091.17%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -24.39%
Return on Equity (ttm) -41.11%

Income Statement

Revenue (ttm) 9.66M USD
Revenue Per Share (ttm) 0.17 USD
Quarterly Revenue Growth (yoy) 24.39%
Gross Profit (ttm) -141180000 USD
EBITDA -200584992 USD
Net Income Avi to Common (ttm) -192154000 USD
Diluted EPS (ttm) -3.38
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 586.3M USD
Total Cash Per Share (mrq) 8.28 USD
Total Debt (mrq) 10.11M USD
Total Debt/Equity (mrq) 1.81 USD
Current Ratio (mrq) 12.419
Book Value Per Share (mrq) 7.893

Cash Flow Statement

Operating Cash Flow (ttm) -155660992 USD
Levered Free Cash Flow (ttm) -85234624 USD

Profile of Avidity Biosciences

Country United States
State CA
City San Diego
Address 10578 Science Center Drive
ZIP 92121
Phone 858 401 7900
Website https://www.aviditybiosciences.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 186

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease is under phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of Duchenne Muscular Dystrophy, which is under phase 1/2 clinical trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy is in phase 1/2 clinical trial. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

Q&A For Avidity Biosciences Stock

What is a current RNA stock price?

Avidity Biosciences RNA stock price today per share is 23.93 USD.

How to purchase Avidity Biosciences stock?

You can buy RNA shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Avidity Biosciences?

The stock symbol or ticker of Avidity Biosciences is RNA.

Which industry does the Avidity Biosciences company belong to?

The Avidity Biosciences industry is Biotechnology.

How many shares does Avidity Biosciences have in circulation?

The max supply of Avidity Biosciences shares is 79.72M.

What is Avidity Biosciences Price to Earnings Ratio (PE Ratio)?

Avidity Biosciences PE Ratio is now.

What was Avidity Biosciences earnings per share over the trailing 12 months (TTM)?

Avidity Biosciences EPS is -2.91 USD over the trailing 12 months.

Which sector does the Avidity Biosciences company belong to?

The Avidity Biosciences sector is Healthcare.

Avidity Biosciences RNA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Global Market Composite NQGM 2185.85 USD
-0.31
2177.48 USD 2204.21 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD